NEW YORK, June 27 - Monsanto has licensed the Rosetta Resolver gene expression data analysis system from Rosetta Inpharmatics, Rosetta said Wednesday. 

Financial details of the transaction were not disclosed. The Resolver system, Rosetta's flagship product, is exclusively distributed by Agilent Technologies, based in Palo Alto, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.